MSF's publications are an expression of our belief in the principle of témoignage, or bearing witness, and the belief that we are accountable to those we work for and with. Sharing news about our activities and reflecting on them, offering critiques when necessary, are therefore crucial aspects of our work.

View and download these publications below.

To view the U.S. Annual Reports or International Activity Reports, please visit the Annual Reports page.

Country/Region

Topic

October 04, 2017

The international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) opens Forced From Home this week in Seattle. The interactive exhibit seeks to tell the individual stories of the more than 65 million displaced people worldwide, and to help visitors understand the humanitarian consequences of displacement. Forced From Home exhibitions have already toured Boulder and Salt Lake City in September, welcoming more than 6,000 visitors.

September 05, 2017

The international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) opened Forced From Home, a traveling, interactive, outdoor exhibition on the global refugee and migration crisis, this week in Boulder.

August 31, 2017

Pharmaceutical company Chemo Group announced today that it will make a drug to treat the neglected tropical disease Chagas available to people in the United States. The U.S. Food and Drug Administration’s approval of the drug, benznidazole, means that Chagas pediatric patients in the U.S. could receive access to a therapy that Doctors Without Borders/Médecins Sans Frontières (MSF) has been using for decades to treat people living with Chagas across Latin America.

August 09, 2017

More than 32,000 people who fled the Kasaï region in the Democratic Republic of Congo have settled in a series of camps in northern Angola.

July 06, 2017

Ahead of the G20 summit in Hamburg, where global health is on the agenda for the first time, the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) called on G20 leaders to follow through on the declaration made by their health ministers in late May.

July 05, 2017

Two days ahead of the G20 summit in Germany, the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) and the Stop TB Partnership released a report that shows countries are lagging behind in tackling tuberculosis (TB), introducing the best diagnostic devices, and implementing globally-recommended policies. The third edition of the “Out of Step” report reviews TB policies and practices in 29[1] countries–which account for 82 percent of the global TB burden–and shows that countries can do much more to prevent, diagnose, and treat people affected by TB.

June 27, 2017

A leaked draft of President Trump’s executive order on drug pricing reveals that the White House will perpetuate policies that have led to a broken biomedical research and development (R&D) system and raise drug prices around the world, said the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF).

June 26, 2017

As U.S. President Donald Trump and Indian Prime Minister Narendra Modi meet at the White House today, Doctors Without Borders/Médecins Sans Frontières (MSF) warned that U.S. pressure on India to change its drug regulatory and patent system could result in millions of people in the U.S. and around the world losing their lifeline of affordable medicines. As an international medical humanitarian organization that relies on affordable generic medicines produced in India to run its medical programs in more than 60 countries, MSF urged Modi to stand strong and protect India’s role as the “pharmacy of the developing world.”

June 08, 2017

This week, the US House’s Energy and Commerce Committee passed legislation that fails to fix the Food and Drug Administration’s Priority Review Voucher (PRV) program for neglected diseases. An amendment included in the FDA Reauthorization Act (FDARA) of 2017 makes changes to the neglected disease PRV program, but it doesn’t fix the major problems that prevent it from working the way it was intended.

Pages

October 04, 2017

The international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) opens Forced From Home this week in Seattle. The interactive exhibit seeks to tell the individual stories of the more than 65 million displaced people worldwide, and to help visitors understand the humanitarian consequences of displacement. Forced From Home exhibitions have already toured Boulder and Salt Lake City in September, welcoming more than 6,000 visitors.

September 05, 2017

The international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) opened Forced From Home, a traveling, interactive, outdoor exhibition on the global refugee and migration crisis, this week in Boulder.

August 31, 2017

Pharmaceutical company Chemo Group announced today that it will make a drug to treat the neglected tropical disease Chagas available to people in the United States. The U.S. Food and Drug Administration’s approval of the drug, benznidazole, means that Chagas pediatric patients in the U.S. could receive access to a therapy that Doctors Without Borders/Médecins Sans Frontières (MSF) has been using for decades to treat people living with Chagas across Latin America.

August 09, 2017

More than 32,000 people who fled the Kasaï region in the Democratic Republic of Congo have settled in a series of camps in northern Angola.

July 06, 2017

Ahead of the G20 summit in Hamburg, where global health is on the agenda for the first time, the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) called on G20 leaders to follow through on the declaration made by their health ministers in late May.

July 05, 2017

Two days ahead of the G20 summit in Germany, the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) and the Stop TB Partnership released a report that shows countries are lagging behind in tackling tuberculosis (TB), introducing the best diagnostic devices, and implementing globally-recommended policies. The third edition of the “Out of Step” report reviews TB policies and practices in 29[1] countries–which account for 82 percent of the global TB burden–and shows that countries can do much more to prevent, diagnose, and treat people affected by TB.

June 27, 2017

A leaked draft of President Trump’s executive order on drug pricing reveals that the White House will perpetuate policies that have led to a broken biomedical research and development (R&D) system and raise drug prices around the world, said the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF).

June 26, 2017

As U.S. President Donald Trump and Indian Prime Minister Narendra Modi meet at the White House today, Doctors Without Borders/Médecins Sans Frontières (MSF) warned that U.S. pressure on India to change its drug regulatory and patent system could result in millions of people in the U.S. and around the world losing their lifeline of affordable medicines. As an international medical humanitarian organization that relies on affordable generic medicines produced in India to run its medical programs in more than 60 countries, MSF urged Modi to stand strong and protect India’s role as the “pharmacy of the developing world.”

June 08, 2017

This week, the US House’s Energy and Commerce Committee passed legislation that fails to fix the Food and Drug Administration’s Priority Review Voucher (PRV) program for neglected diseases. An amendment included in the FDA Reauthorization Act (FDARA) of 2017 makes changes to the neglected disease PRV program, but it doesn’t fix the major problems that prevent it from working the way it was intended.

Pages